American Cancer Society. (2014, July 2). Cancer - Unknown Primary. Atlanta, GA. Retrieved on 08/25/2014. Retrieved from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003092-pdf.pdf.
Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario.
Fizazi K, Greco FA, Pavlidis N, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2011). Annals of Oncology. Oxford University Press. 22(Supplement 5): vi64-vi68 doi: 10.1093/annoc/mdr389.
Greco FA & Hainsworth JD. Cancer of unknown primary site. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles & Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 113:1720-1737.
Hainsworth JD, Greco FA. Chemotherapy of carcinoma of unknown primary site. Perry MC, Doll DC, Freter CE. (2012). Perry's The Chemotherapy Source Book. (5th Edition). Lippincott Williams Wilkins. Chapter 37. Retrieved from: http://www.lwwoncology.com.
Lee J, Kim D-W, Kim, J, et al. Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis. (2013). British Journal of Cancer. Nature Publishing Group. 108: 39-48.
National Comprehensive Cancer Network. Occult Primary (Cancer of Unknown Primary [CUP]) (Version 3.2014). Retrieved on 7/7/2014. Retrieved from: http://www.nccn.org/professionals/physician_gls/pdf/occult.pdf.×